Page last updated: 2024-11-01

norfloxacin and Carcinoma

norfloxacin has been researched along with Carcinoma in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bykowska, A1
Komarnicka, UK1
Jeżowska-Bojczuk, M1
Kyzioł, A1
Blondin, C1
Costa, P1
Bressolle, F1
Navratil, H1
Galtier, M1

Other Studies

2 other studies available for norfloxacin and Carcinoma

ArticleYear
Cu
    Journal of inorganic biochemistry, 2018, Volume: 181

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt

2018
Norfloxacin concentrations in plasma and human epididymal tissue after repeated oral administration.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Epididymis; Humans; Male; Norfloxacin; Pro

1991